Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer

被引:51
作者
Rubins, JB
Dunitz, J
Rubins, HB
Maddaus, MA
Niewoehner, DE
机构
[1] Vet Affairs Med Ctr, Dept Med, Div Pulm Dis, Minneapolis, MN 55417 USA
[2] Vet Affairs Med Ctr, Dept Med, Div Gen Internal Med, Minneapolis, MN 55417 USA
[3] Vet Affairs Med Ctr, Dept Thorac Surg, Minneapolis, MN 55417 USA
[4] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S0022-5223(98)70007-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine whether measurement of preoperative serum carcinoembryonic antigen concentrations adds useful prognostic data to current preoperative staging of lung cancer by computed tomography, bronchoscopy, and mediastinoscopy. Methods: A prospective cohort study of 130 consecutive patients mas evaluated for suspected lung cancer from July 1991 through December 1992 at a university-affiliated Veterans Affairs Medical Center. Serum concentrations of carcinoembryonic antigen were measured before diagnosis, staging, or resection of cancer. Results: Malignant disease mas diagnosed by bronchoscopy, needle biopsy, mediastinoscopy, or resection in 111 of 130 patients, In the 50 patients undergoing resection with curative intent, multivariate analysis indicated that carcinoembryonic antigen was a significant predictor of survival independent of patient age, pathologic stage, histologic type, and tumor size (P = .0357), Conclusions: Elevated preoperative serum concentrations of carcinoembryonic antigen predict a poor prognosis for lung cancer independent of other conventional staging parameters and have an adjunctive role in the staging of lung cancer.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 15 条
[1]  
CONCANNON JP, 1978, CANCER, V42, P1477, DOI 10.1002/1097-0142(197809)42:3+<1477::AID-CNCR2820420818>3.0.CO
[2]  
2-E
[3]  
DENT PB, 1978, CANCER, V42, P1484, DOI 10.1002/1097-0142(197809)42:3+<1484::AID-CNCR2820420819>3.0.CO
[4]  
2-J
[5]   Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer [J].
Diez, M ;
Torres, A ;
Maestro, ML ;
Ortega, MD ;
Gomez, A ;
Pollan, M ;
Lopez, JA ;
Picardo, A ;
Hernando, F ;
Balibrea, JL .
BRITISH JOURNAL OF CANCER, 1996, 73 (10) :1248-1254
[6]   CARCINOEMBRYONIC ANTIGEN AND PROGNOSIS AFTER RADICAL SURGERY FOR LUNG-CANCER - IMMUNO-CYTOCHEMICAL LOCALIZATION AND SERUM LEVELS [J].
FORD, CHJ ;
STOKES, HJ ;
NEWMAN, CE .
BRITISH JOURNAL OF CANCER, 1981, 44 (02) :145-153
[7]  
GRAZIANO SL, 1994, CANCER RES, V54, P2908
[8]   Do molecular markers predict survival in non-small-cell lung cancer? [J].
Greatens, TM ;
Niehans, GA ;
Rubins, JB ;
Jessurun, J ;
Kratzke, RA ;
Maddaus, MA ;
Niewoehner, DE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) :1093-1097
[9]  
*HIH, 1981, BRIT MED J, V282, P373
[10]   PREOPERATIVE CARCINOEMBRYONIC ANTIGEN LEVEL AS A PROGNOSTIC INDICATOR IN RESECTED PRIMARY LUNG-CANCER [J].
ICARD, P ;
REGNARD, JF ;
ESSOMBA, A ;
PANEBIANCO, V ;
MAGDELEINAT, P ;
LEVASSEUR, P .
ANNALS OF THORACIC SURGERY, 1994, 58 (03) :811-814